Feasibility and Reliability of SmartWatch to Obtain 3-Lead Electrocardiogram Recordings

Amirali Behzadi, Alireza Sepehri Shamloo, Konstantinos Mouratis, Gerhard Hindricks, Arash Arya, Andreas Bollmann, Amirali Behzadi, Alireza Sepehri Shamloo, Konstantinos Mouratis, Gerhard Hindricks, Arash Arya, Andreas Bollmann

Abstract

Some of the recently released smartwatch products feature a single-lead electrocardiogram (ECG) recording capability. The reliability of obtaining 3-lead ECG with smartwatches is yet to be confirmed in a large study. This study aimed to assess the feasibility and reliability of smartwatch to obtain 3-lead ECG recordings, the classical Einthoven ECG leads I-III compared to standard ECG. To record lead I, the watch was worn on the left wrist and the right index finger was placed on the digital crown for 30 s. For lead II, the watch was placed on the lower abdomen and the right index finger was placed on the digital crown for 30 s. For lead III, the same process was repeated with the left index finger. Spearman correlation and Bland-Altman tests were used for data analysis. A total of 300 smartwatch ECG tracings were successfully obtained. ECG waves' characteristics of all three leads obtained from the smartwatch had a similar duration, amplitude, and polarity compared to standard ECG. The results of this study suggested that the examined smartwatch (Apple Watch Series 4) could obtain 3-lead ECG tracings, including Einthoven leads I, II, and III by placing the smartwatch on the described positions.

Keywords: Apple Watch; electrocardiogram; feasibility; mobile health; reliability; smartwatch; wearables.

Conflict of interest statement

Andreas Bollmann and Gerhard Hindricks report research grants from Pfizer, Abbott and Boston Scientific to the institution without personal financial benefits. Other authors do not declare any conflict of interest.

Figures

Figure 1
Figure 1
The positioning of the Apple Watch Series 4 for obtaining leads 1, II, and III using the Einthoven triangle. In the Apple Watch, the negative electrode is placed in the digital crown and the positive electrode is on the back crystal of the watch.
Figure 2
Figure 2
Principles of electrocardiogram assessment.
Figure 3
Figure 3
Comparison of a 3-lead ECG recorded by an Apple Watch 4 (left side) and a standard ECG device (right side).
Figure 4
Figure 4
A sample of temporary artifact (around one second) due to instability of the Apple Watch 4 on a patient’s wrist.

References

    1. Taggar J.S., Coleman T., Lewis S., Heneghan C., Jones M. Accuracy of methods for diagnosing atrial fibrillation using 12-lead ECG: A systematic review and meta-analysis. Int. J. Cardiol. 2015;184:175–183. doi: 10.1016/j.ijcard.2015.02.014.
    1. Bansal A., Joshi R. Portable out-of-hospital electrocardiography: A review of current technologies. J. Arrhythmia. 2018;34:129–138. doi: 10.1002/joa3.12035.
    1. Pevnick J.M., Birkeland K., Zimmer R., Elad Y., Kedan I. Wearable technology for cardiology: An update and framework for the future. Trends Cardiovasc. Med. 2018;28:144–150. doi: 10.1016/j.tcm.2017.08.003.
    1. Perez M.V., Mahaffey K.W., Hedlin H., Rumsfeld J.S., Garcia A., Ferris T., Balasubramanian V., Russo A.M., Rajmane A., Cheung L., et al. Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation. N. Engl. J. Med. 2019;381:1909–1917. doi: 10.1056/NEJMoa1901183.
    1. Guo Y., Wang H., Zhang H., Liu T., Liang Z., Xia Y., Yan L., Xing Y., Shi H., Li S., et al. Mobile Photoplethysmographic Technology to Detect Atrial Fibrillation. J. Am. Coll. Cardiol. 2019;74:2365–2375. doi: 10.1016/j.jacc.2019.08.019.
    1. Mehta D.D., Nazir N.T., Trohman R.G., Volgman A.S. Single-lead portable ECG devices: Perceptions and clinical accuracy compared to conventional cardiac monitoring. J. Electrocardiol. 2015;48:710–716. doi: 10.1016/j.jelectrocard.2015.04.017.
    1. Avila C.O. Novel Use of Apple Watch 4 to Obtain 3-Lead Electrocardiogram and Detect Cardiac Ischemia. Perm. J. 2019;23:19–25.
    1. Isakadze N., Martin S.S. How useful is the smartwatch ECG? Trends Cardiovasc. Med. 2019 doi: 10.1016/j.tcm.2019.10.010. in press.
    1. Shamloo A.S., Bollmann A., Dagres N., Arya A., Hindricks G. Smart Watch Devices for Atrial Fibrillation Screening: It Has to Start Somewhere. J. Am. Coll. Cardiol. 2020;75:1364–1365. doi: 10.1016/j.jacc.2019.10.063.
    1. Nielsen J.C., Lin Y.J., Figueiredo M.J.d.O., Shamloo A.S., Alfie A., Boveda S., Dagres N., Di Toro D., Eckhardt L.L., Ellenbogen K., et al. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: Use the right tool for the right outcome, in the right population. EP Eur. 2020;22:1147–1148.
    1. Cho D.J. Beyond the early adopter: The smartwatch ECG goes mainstream. Trends Cardiovasc. Med. 2019 doi: 10.1016/j.tcm.2019.11.003. in press.
    1. Gil M.C. Standard and Precordial Leads Obtained with an Apple Watch. Ann. Intern. Med. 2020;172:436–437. doi: 10.7326/M19-2018.
    1. Samol A., Bischof K., Luani B., Pascut D., Wiemer M., Kaese S. Patient Directed Recording of a Bipolar Three-Lead Electrocardiogram using a Smartwatch with ECG Function. J. Vis. Exp. 2019;11:1–6. doi: 10.3791/60715.
    1. Samol A., Bischof K., Luani B., Pascut D., Wiemer M., Kaese S. Recording of Bipolar Multichannel ECGs by a Smartwatch: Modern ECG Diagnostic 100 Years after Einthoven. Sensors. 2019;19:2894. doi: 10.3390/s19132894.
    1. Samol A., Bischof K., Luani B., Pascut D., Wiemer M., Kaese S. Single-Lead ECG Recordings Including Einthoven and Wilson Leads by a Smartwatch: A New Era of Patient Directed Early ECG Differential Diagnosis of Cardiac Diseases? Sensors. 2019;19:4377. doi: 10.3390/s19204377.
    1. Li K.H.C., White F.A., Tipoe T., Liu T., Wong M.C., Jesuthasan A., Baranchuk A., Tse G., Yan B.P. The Current State of Mobile Phone Apps for Monitoring Heart Rate, Heart Rate Variability, and Atrial Fibrillation: Narrative Review. JMIR mHealth uHealth. 2019;7:e11606. doi: 10.2196/11606.
    1. Schukraft S., Mancinetti M., Hayoz D., Faucherre Y., Cook S., Arroyo D., Puricel S. Handheld ECG Tracking of in-hOspital Atrial Fibrillation the HECTO-AF trial Clinical Study Protocol. Trials. 2019;20:92. doi: 10.1186/s13063-019-3189-7.
    1. Verbrugge F.H., Proesmans T., Vijgen J., Mullens W., Rivero-Ayerza M., Van Herendael H., Vandervoort P., Nuyens D. Atrial fibrillation screening with photo-plethysmography through a smartphone camera. EP Eur. 2019;21:1167–1175. doi: 10.1093/europace/euz119.
    1. Wasserlauf J., You C., Patel R., Valys A., Albert D., Passman R. Smartwatch Performance for the Detection and Quantification of Atrial Fibrillation. Circ. Arrhythmia Electrophysiol. 2019;12:e006834. doi: 10.1161/CIRCEP.118.006834.
    1. Raja J.M., Elsakr C., Roman S., Cave B., Pour-Ghaz I., Nanda A., Maturana M., Khouzam R.N. Apple Watch, Wearables, and Heart Rhythm: Where do we stand? Ann. Transl. Med. 2019;7:417. doi: 10.21037/atm.2019.06.79.
    1. Sajeev J.K., Koshy A.N., Teh A.W. Wearable devices for cardiac arrhythmia detection: A new contender? Intern. Med. J. 2019;49:570–573. doi: 10.1111/imj.14274.
    1. Postema P.G., Wilde A.A.M. The measurement of the QT interval. Curr. Cardiol. Rev. 2014;10:287–294. doi: 10.2174/1573403X10666140514103612.
    1. Rautaharju P.M., Surawicz B., Gettes L.S., Bailey J.J., Childers R., Deal B.J., Gorgels A., Hancock E.W., Josephson M., Kligfield P., et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: Part IV: The ST segment, T and U waves, and the QT interval: A scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: Endorsed by the International Society for Computerized Electrocardiology. Circulation. 2009;119:e241–e250.
    1. Muhlestein J.B., Le V., Albert D., Moreno F.L., Anderson J.L., Yanowitz F., Vranian R.B., Barsness G.W., Bethea C.F., Severance H.W., et al. Smartphone ECG for evaluation of STEMI: Results of the ST LEUIS Pilot Study. J. Electrocardiol. 2015;48:249–259. doi: 10.1016/j.jelectrocard.2014.11.005.
    1. Nigolian A., Dayal N., Nigolian H., Stettler C., Burri H. Diagnostic accuracy of multi-lead ECGs obtained using a pocket-sized bipolar handheld event recorder. J. Electrocardiol. 2018;51:278–281. doi: 10.1016/j.jelectrocard.2017.11.004.
    1. AlGhatrif M., Lindsay J. A brief review: History to understand fundamentals of electrocardiography. J. Community Hosp. Intern. Med. Perspect. 2012;2:14383. doi: 10.3402/jchimp.v2i1.14383.
    1. Frisch D.R. A Novel Technique to Expand the Electrocardiographic Recording Capability from an Apple Watch. Am. J. Med. 2019;132:940–941. doi: 10.1016/j.amjmed.2019.03.005.
    1. Ahmed A.S., Golden K.M., Foreman J.R., Padanilam B.J. Using a smartwatch to identify the morphology of atrial flutter. HeartRhythm Case Rep. 2020 doi: 10.1016/j.hrcr.2020.06.021. in press.
    1. Drexler M., Elsner C., Gabelmann V., Gori T., Münzel T. Apple Watch detecting coronary ischaemia during chest pain episodes or an apple a day may keep myocardial infarction away. Eur. Heart J. 2020;41:2224. doi: 10.1093/eurheartj/ehaa290.
    1. Rajakariar K., Koshy A.N., Sajeev J.K., Nair S., Roberts L., Teh A.W. Modified positioning of a smartphone based single-lead electrocardiogram device improves detection of atrial flutter. J. Electrocardiol. 2018;51:884–888. doi: 10.1016/j.jelectrocard.2018.07.008.
    1. Dasari T.W., Roe M.T., Chen A.Y., Peterson E.D., Giugliano R.P., Fonarow G.C., Saucedo J.F. Impact of time of presentation on process performance and outcomes in ST-segment-elevation myocardial infarction: A report from the American Heart Association: Mission Lifeline program. Circ. Cardiovasc. Qual. Outcomes. 2014;7:656–663. doi: 10.1161/CIRCOUTCOMES.113.000740.
    1. Foo C.Y., Bonsu K.O., Nallamothu B.K., Reid C.M., Dhippayom T., Reidpath D.D., Chaiyakunapruk N. Coronary intervention door-to-balloon time and outcomes in ST-elevation myocardial infarction: A meta-analysis. Heart Br. Cardiac. Soc. 2018;104:1362–1369. doi: 10.1136/heartjnl-2017-312517.
    1. Strik M., Caillol T., Ramirez F.D., Abu-Alrub S., Marchand H., Welte N., Ritter P., Haïssaguerre M., Ploux S., Bordachar P. Validating QT-Interval Measurement Using the Apple Watch ECG to Enable Remote Monitoring During the COVID-19 Pandemic. Circulation. 2020;142:416–418. doi: 10.1161/CIRCULATIONAHA.120.048253.
    1. Bailey J.J., Berson A.S., Garson A., Jr., Horan L.G., Macfarlane P.W., Mortara D.W., Zywietz C. Recommendations for standardization and specifications in automated electrocardiography: Bandwidth and digital signal processing. A report for health professionals by an ad hoc writing group of the Committee on Electrocardiography and Cardiac Electrophysiology of the Council on Clinical Cardiology, American Heart Association. Circulation. 1990;81:730–739.

Source: PubMed

3
Iratkozz fel